USPTO serial 97765090
CENCORA
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- EUBANK, REBECCA A
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with CENCORA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CONSHOHOCKEN, PA, US
Conshohocken, PA, US
CONSHOHOCKEN, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anita B. Polott
Anita B. Polott MORGAN, LEWIS & BOCKIUS LLP1111 PENNSYLVANIA AVENUE, NWATTENTION: TMSUWASHINGTON, DC 20004-2541Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Medical analysis services; Medical analysis services, namely, analyzing and reporting in the field of human disease treatment; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing medical provider and care information; providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; information services for the pharmaceutical and medical sectors; counseling services related to workplace and personnel health; healthcare services; services of information on medical substances; analysing and reporting of discussions about human disease treatment; administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable information and analysis about legislative regulatory developments in the field of healthcare; telehealth services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; telehealth services, namely, providing patients with health information relating to their medical condition; beauty and health care advice services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; Providing information on health and nutrition in the field of animal management; consulting services in the field of animal husbandry, medical and healthcare management, namely, medical research, development, analysis and identification of processes to efficiently raise individual animals; providing a website featuring information to retail customers of pharmacies over a global computer network with regard to health, wellness and pharmacy news; providing information, news and commentary in the field of current events relating to the healthcare industry and healthcare legislation and regulation; providing on-line information, news and commentary in the field of health and wellness relating to healthy diets and activities for male and female infants, children, teenagers, adults and seniors and to illnesses and treatments affecting them; pharmaceutical consultation; providing medical information | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 21, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 21, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 21, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 3, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 3, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 5, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 4, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 4, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 4, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 5, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 5, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 4, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 4, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 6, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 11, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 11, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 9, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 9, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 9, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 9, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 9, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 18, 2024 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Apr 18, 2024 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 18, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 18, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 16, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 24, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 13, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 26, 2023 | NWAP | NEW APPLICATION ENTERED | — |